SARS-COV-2 Vaccinations in RMD patients

The EULAR Task Force on COVID-19 has updated the EULAR View-points on SARS-CoV-2 vaccination in patients with RMDs (December 2021).

The information addresses questions, including considerations regarding vaccination effectiveness and safety, the third vaccination dose, booster vaccination, combination with Influenza and Pneumococcus vaccination, among other frequently asked questions by people with RMDs.

EULAR President, Prof Annamaria Iagnocco, invites you to share the link with your axSpA community.

Other NEWS

World AS Day 2022

Raising awareness of axSpA This year our World AS Day social …

Read More
Vale Margaret Lewington

It is with great sadness that we announce the …

Read More
New Trustee

      ASIF is delighted and honoured to welcome …

Read More
Languages: